Moteur de recherche d’entreprises européennes
Financement de l’UE (6 379 671 €) : SOINS PERSONNALISÉS INTÉGRÉS POUR LES PATIENTS ATTEINTS DE MALADIES CHRONIQUES AVANCÉES AFIN D’AMÉLIORER LA SANTÉ ET LA QUALITÉ DE VIE Hor08/11/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
SOINS PERSONNALISÉS INTÉGRÉS POUR LES PATIENTS ATTEINTS DE MALADIES CHRONIQUES AVANCÉES AFIN D’AMÉLIORER LA SANTÉ ET LA QUALITÉ DE VIE
Due to population ageing and advances in medical science, people with chronic diseases –including advanced severe life-threatening chronic diseases- live longer. Challenges are how to sustain quality independent living for the patient; support caregivers facing an increasing burden; create sustainable healthcare and social care systems with limited resources. ADLIFE aims to provide a solution for the integration of therapies and approaches targeting early detection and assessment of deterioration, advanced and well-coordinated care planning and integrated supportive care to enhance quality of life, reduce suffering and accelerate recovery for these patients and their families. It will deploy developed and validated personalised digital solutions for integrated supportive care based on H2020 projects C3-Cloud and Power2DM, previously tested in two health systems. The ADLIFE Toolbox solutions include: a Personalised Care Plan Management Platform, Clinical Decision Support Services; Interoperability Solutions and Patient Empowerment Platform with Just-In Time Adaptive Intervention Delivery Engine. The ADLIFE system will be deployed through large-scale pilots in 7 countries and Health Systems, involve 577 healthcare professionals from 75 hospitals, clinics and primary care services. It will prove that intelligent, collaborative digital solutions can enable care teams, patients and caregivers to improve or better maintain health in patients with advanced chronic disease (over 200,000 in the participating regions). It will test its effectiveness in 882 patients and 1243 caregivers. ADLIFE will demonstrate significant outcomes-based efficiency gains in health and care delivery enhancing seamless care coordination, avoiding gaps and overlaps in care. The ADLIFE ICT Toolbox and the evidence behind this digitally-enabled approach from the 7 reference sites will be strongly disseminated to multiple stakeholders and decision makers in Europe both online and in-person actions
| Asociación Instituto de Investigación en Sistemas de Salud-Biosistemak | 1 143 741 € |
| ASSUTA ASHDOD Ltd. | 779 849 € |
| ASSUTA MEDICAL CENTERS Ltd. | 0,00 € |
| GESUNDER WERRA-MEISSNER-KREIS GmbH | 0,00 € |
| MACCABI SHEIRUTEI BRIUT Foundation | 0,00 € |
| NTT Data Spain SL | 611 002 € |
| OPTIMEDIS AG | 557 900 € |
| Region Jamtland Harjedalen | 328 738 € |
| Region Syddanmark | 600 550 € |
| Servicio Vasco de Salud Osakidetza | 0,00 € |
| SRDC Yazilim Arastirma VE Gelistirme VE Danismanlik Ticaret Anonim Sirketi | 589 628 € |
| Szpital Specjalistyczny im A Falkiewicza WE Wroclawiu | 8 254,42 € |
| THE European Institute for Innovation Through Health Data | 197 250 € |
| The University of Birmingham | 210 616 € |
| University Hospitals Coventry and Warwickshire National Health Service Trust | 353 188 € |
| University of Strathclyde | 623 352 € |
| University of Warwick | 375 603 € |
https://cordis.europa.eu/project/id/875209
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.